Palbociclib-Induced Posterior Reversible Encephalopathy Syndrome: A Previously Unreported Toxicity

J Oncol Pract. 2019 Feb;15(2):119-121. doi: 10.1200/JOP.18.00643.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Biomarkers
  • Breast Neoplasms / complications*
  • Breast Neoplasms / drug therapy
  • Female
  • Humans
  • Magnetic Resonance Imaging / methods
  • Middle Aged
  • Piperazines / administration & dosage
  • Piperazines / adverse effects*
  • Piperazines / therapeutic use
  • Posterior Leukoencephalopathy Syndrome / diagnosis*
  • Posterior Leukoencephalopathy Syndrome / etiology*
  • Protein Kinase Inhibitors / administration & dosage
  • Protein Kinase Inhibitors / adverse effects*
  • Protein Kinase Inhibitors / therapeutic use
  • Pyridines / administration & dosage
  • Pyridines / adverse effects*
  • Pyridines / therapeutic use

Substances

  • Antineoplastic Agents
  • Biomarkers
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyridines
  • palbociclib